Search bioRxiv⌕ Search

Biology subjects

Walters, W.

Publications and source records attributed to Walters, W..

5 recordsLinked to original sources

Identifying and Addressing Systematic Data Leakage in Protein-Ligand Affinity Benchmarks

Accurate prediction of protein-ligand binding affinity is a crucial goal in structure-based drug discovery, with the potential to significantly shorten development timelines. Recently, a new wave of machine learning models based on co-folding, such as Boltz-2 and IsoDDE, has demonstrated performance that matches or exceeds that of gold-standard physics-based methods like Free Energy Perturbation (FEP). This paper provides a critical assessment of these claims, revealing that current benchmarks are heavily influenced by data leakage, and proposes a new benchmark that explicitly controls for data leakage. We demonstrate that splitting by protein-sequence identity is inherently insufficient to prevent data leakage due to "target mirroring," in which homologous proteins with low overall sequence identity still exhibit highly correlated binding profiles. Our meta-analysis of documents in the ChEMBL 36 database identifies more than 6,000 such assay pairs and finds that leakage persists for sequence-identity thresholds as low as 0.2, well below the values commonly used in benchmarks today. Additionally, we show that a ligand-only baseline model, which lacks protein structural information, achieves surprisingly high performance on the FEP+ 4 and OpenFE benchmarks (r = 0.66 and r = 0.36, respectively). Our results indicate that current benchmarks tend to reward models for memorizing training data and exploiting localized leakage rather than truly learning biophysical principles. To address this issue, we propose the Novelty-Tiered Affinity Benchmark, in which the test data is partitioned into ligand novelty tiers. In the most challenging tier (Tanimoto similarity < 0.35), ligand-only models perform notably worse (r = 0.14), offering a clear baseline for evaluating genuine generalization. We argue that the field must move beyond sequence-based splits to ensure that AI-driven discovery translates into successful prospective laboratory research.

Molecular Biology↗

Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations

Glioblastoma (GBM) remains the most common and lethal adult malignant primary brain cancer with few treatment options. A significant issue hindering GBM therapeutic development is intratumor heterogeneity. GBM tumors contain neoplastic cells within a spectrum of different transcriptional states. Identifying effective therapeutics requires a platform that predicts the differential sensitivity and resistance of these states to various treatments. Here, we developed a novel framework, ISOSCELES (Inferred cell Sensitivity Operating on the integration of Single-Cell Expression and L1000 Expression Signatures), to quantify the cellular drug sensitivity and resistance landscape. Using single-cell RNA sequencing of newly diagnosed and recurrent GBM tumors, we identified compounds from the LINCS L1000 database with transcriptional response signatures selectively discordant with distinct GBM cell states. We validated the significance of these findings in vitro, ex vivo, and in vivo, and identified a novel combination of an OLIG2 inhibitor and Depatux-M for GBM. Our studies suggest that ISOSCELES identifies cell states sensitive and resistant to targeted therapies in GBM and that it can be applied to identify new synergistic combinations. HighlightsO_LIIntegration of GBM single-cell RNA sequencing data with L1000-derived drug response signatures facilitates clustering of tumor cells and small molecules on cell-drug connectivity. C_LIO_LICell-drug connectivity predicts the identities of drug-sensitive and resistant cell states. C_LIO_LIIn silico perturbation analysis using cell-drug connectivity predicts drug-induced changes in the cell-drug connectivity landscape in vivo. C_LIO_LIIn silico perturbation analysis to predict drug-induced changes in the tumor cell-drug connectivity landscape predicts drug combinations that synergize in vivo to extend survival. C_LI

cancer biology↗

RAPID RESISTANCE TO BET INHIBITORS IS MEDIATED BY FGFR1 IN GLIOBLASTOMA

Bromodomain and extra-terminal domain (BET) proteins are therapeutic targets in several cancers including the most common malignant adult brain tumor glioblastoma (GBM). Multiple small molecule inhibitors of BET proteins have been utilized in preclinical and clinical studies. Unfortunately, BET inhibitors have not shown efficacy in clinical trials enrolling GBM patients. One possible reason for this may stem from resistance mechanisms that arise after prolonged treatment within a clinical setting. However, the mechanisms and timeframe of resistance to BET inhibitors in GBM is not known. To identify the temporal order of resistance mechanisms in GBM we performed quantitative proteomics using multiplex-inhibitor bead mass spectrometry and demonstrated that intrinsic resistance to BET inhibitors in GBM treatment occurs rapidly within hours and involves the fibroblast growth factor receptor 1 (FGFR1) protein. Additionally, small molecule inhibition of BET proteins and FGFR1 simultaneously induces synergy in reducing GBM tumor growth in vitro and in vivo. Further, FGFR1 knockdown synergizes with BET inhibitor mediated reduction of GBM cell proliferation. Collectively, our studies suggest that co-targeting BET and FGFR1 may dampen resistance mechanisms to yield a clinical response in GBM.

cancer biology↗

Gut microbiota influence B cell function in a TLR5-dependent manner

Toll-like receptor (TLR) 5-deficient mice display aberrantly low levels of flagellin-specific antibodies (Flic-IgA) secreted into the gut, combined with excess bacterial flagellin in the gut, and together these attributes define microbiome dysbiosis (T5-dysbiosis). How TLR5 signaling deficiency results in T5-dysbiosis is unclear. Here, we address the role of B cells in T-dysbiosis. We observed that B cells do not express TLR5, and that B cell transplantation from TLR5-/- mouse donors into B-cell deficient mice resulted in a slight reduction in Flic-IgA levels compared to B-cells from WT donors. Bone marrow transplants from WT and TLR5-/- donors into recipients of both genotypes confirmed that TLR5 signaling by non-hematopoietic cells is required for T5-dysbiosis. We observed TLR5 deficiency was associated with an expanded population of IgA+ B cells. TLR5-/- mice tended to have higher richness for the IgA gene hypervariable region (CDR3 gene) variants. Transplantation of microbiomes from TLR5-/- and WT microbiomes donors into germfree mice resulted in a higher proportion of IgA-secreting B cells, and higher overall fecal IgA and anti-Flic IgA for TLR5-/- microbiome recipients. This observation indicated that the TLR5-/- mouse microbiome elicits an anti-flagellin antibody response that requires TLR5 signaling. Together these results indicate that TLR5 signaling on epithelial cells influences B cell populations and antibody repertoire.

immunology↗

Host diet and evolutionary history explain different aspects of gut microbiome diversity among vertebrate clades

Multiple factors modulate microbial community assembly in the gut, but the magnitude of each can vary substantially across studies. This may be in part due to a heavy reliance on captive animals, which can have very different gut microbiomes versus their wild counterparts. In order to better resolve the influence of evolution and diet on gut microbiome diversity, we generated a large and highly diverse animal distal gut 16S rRNA microbiome dataset, which comprises 80 % wild animals and includes members of Mammalia, Aves, Reptilia, Amphibia, and Actinopterygii. We decoupled the effects of host evolutionary history and diet on gut microbiome diversity and show that each factor explains different aspects of diversity. Moreover, we resolved particular microbial taxa associated with host phylogeny or diet, and we show that Mammalia have a stronger signal of cophylogeny versus non-mammalian hosts. Additionally, our results from ecophylogenetics and co-occurrence analyses suggest that environmental filtering and microbe-microbe interactions differ among host clades. These findings provide a robust assessment of the processes driving microbial community assembly in the vertebrate intestine.

microbiology↗